- Home
- SPCB vs APLT Comparison
SPCB vs APLT Comparison
Compare SPCB & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- APLT
- Stock Information
- Founded
- SPCB 1988
- APLT 2016
- Country
- SPCB Israel
- APLT United States
- Employees
- SPCB N/A
- APLT 36
- Industry
- SPCB Semiconductors
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- SPCB Technology
- APLT Health Care
- Exchange
- SPCB Nasdaq
- APLT Nasdaq
- Market Cap
- SPCB 53.3M
- APLT 44.0M
- IPO Year
- SPCB N/A
- APLT 2019
- Fundamental
- Price
- SPCB $9.72
- APLT $0.33
- Analyst Decision
- SPCB Strong Buy
- APLT Buy
- Analyst Count
- SPCB 1
- APLT 7
- Target Price
- SPCB $18.00
- APLT $6.10
- AVG Volume (30 Days)
- SPCB 166.8K
- APLT 2.3M
- Earning Date
- SPCB 08-14-2025
- APLT 08-06-2025
- Dividend Yield
- SPCB N/A
- APLT N/A
- EPS Growth
- SPCB N/A
- APLT N/A
- EPS
- SPCB 1.89
- APLT N/A
- Revenue
- SPCB $27,831,000.00
- APLT $265,000.00
- Revenue This Year
- SPCB $2.73
- APLT $1,768.13
- Revenue Next Year
- SPCB $22.87
- APLT $292.85
- P/E Ratio
- SPCB $5.16
- APLT N/A
- Revenue Growth
- SPCB 2.90
- APLT N/A
- 52 Week Low
- SPCB $2.55
- APLT $0.30
- 52 Week High
- SPCB $18.95
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- SPCB 47.89
- APLT 43.25
- Support Level
- SPCB $9.61
- APLT $0.30
- Resistance Level
- SPCB $11.14
- APLT $0.36
- Average True Range (ATR)
- SPCB 0.68
- APLT 0.03
- MACD
- SPCB -0.22
- APLT -0.00
- Stochastic Oscillator
- SPCB 17.44
- APLT 22.22
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.